Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
American Journal of Infection Control|November 30, 2023
Catheter-associated urinary tract infection (CAUTI) reduction in a neuroscience intensive care unit: A multidisciplinary approachJamie M McGloin, Patrick Gordon, Baevin Feeser, et al.
Clinical Rheumatology|January 25, 2012
Access to the next wave of biologic therapies (Abatacept and Tocilizumab) for the treatment of rheumatoid arthritis in England and Wales: addressing treatment outside the current NICE guidanceYee Chiu, Andrew J K Ostor, Anthony Hammond, et al.
Lupus Science & Medicine|March 17, 2021
Effects of targeting the transcription factors Ikaros and Aiolos on B cell activation and differentiation in systemic lupus erythematosusFelice Rivellese, Sotiria Manou-Stathopoulou, Daniele Mauro, et al.
Rheumatology (Oxford, England)|April 19, 2026
The incidence, mortality and complications of systemic lupus erythematosus: a population-level cohort study from 2012 to 2023Samir Patel, Mark D Russell, Katie Bechman, et al.
Big Data|July 22, 2016
A Case Study: Analyzing City Vitality with Four Pillars of Activity-Live, Work, Shop, and PlayMatt Griffin, Blake W Nordstrom, Jon Scholes, et al.
BMC Urology|July 29, 2024
Pharmacological non-hormonal treatment options for male infertility: a systematic review and network meta-analysisBassel H Al Wattar, Michael P Rimmer, Jack J Teh, et al.
Rheumatology (Oxford, England)|October 31, 2019
The myositis clinical phenotype associated with anti-Zo autoantibodies: a case series of nine UK patientsSarah L Tansley, Zoe Betteridge, Hui Lu, et al.
The Journal of Rheumatology|December 1, 2004
Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupusPatrick Gordon, Munther A Khamashta, Eric Rosenthal, et al.
Thorax|May 5, 2012
The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaireAmit S Patel, Richard J Siegert, Katherine Brignall, et al.
Rheumatology (Oxford, England)|November 30, 2014
Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroidsFowzia Ibrahim, Ernest Choy, Patrick Gordon, et al.
Pageof 6